Suppr超能文献

伊朗人群中新发与改善代谢综合征的决定因素

Determinant components of newly onset versus improved metabolic syndrome in a population of Iran.

机构信息

Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.

Shiraz HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Sci Rep. 2020 Nov 11;10(1):19563. doi: 10.1038/s41598-020-76531-2.

Abstract

This study aimed to determine the risk factors related to regression and progression of metabolic syndrome, in a 4-year cohort study. A total of 540 individuals (≥ 18 years old) participated in both phase of the study. Participants were categorized into 3 categories of regressed, progressed and unchanged metabolic syndrome (MetS). Demographic, anthropometric and biochemical parameters were assessed for each individual in both phase. Variables differences (delta: Δ) between the two phase of study were calculated. Unchanged group was considered as baseline category. Based on IDF, MetS had been regressed and progressed in 42 participants (7.7%) and 112 (20.7%) participants respectively, in the second phase. More than 47% of people, whose MetS regressed, experienced also NAFLD regression. Results of multiple variable analysis revealed that increased age, positive Δ-TG, and Δ-FBS, significantly increased the odds of MetS progression based on IDF and ATP III definitions, while negative Δ-HDL and Δ-neutrophil to lymph ration increased the odds of progression. On the other hand, negative Δ-TG and positive Δ-HDL significantly increased the odds of Mets regression based of both IDF and ATP III. Management of hypertriglyceridemia, hyperglycemia, and HDL is a critical, non-invasive and accessible approach to change the trend of MetS.

摘要

本研究旨在确定与代谢综合征消退和进展相关的风险因素,采用了一项为期 4 年的队列研究。共有 540 名(≥18 岁)个体参与了研究的两个阶段。参与者被分为代谢综合征(MetS)消退、进展和不变的 3 个类别。在两个阶段都评估了每个个体的人口统计学、人体测量学和生化参数。计算了两个阶段之间的变量差异(差值:Δ)。不变组被视为基线类别。根据 IDF,在第二阶段,42 名(7.7%)和 112 名(20.7%)参与者的 MetS 分别消退和进展。超过 47%的 MetS 消退者也经历了非酒精性脂肪性肝病(NAFLD)的消退。多变量分析的结果表明,基于 IDF 和 ATP III 定义,年龄增长、正Δ-TG 和Δ-FBS 显著增加了 MetS 进展的几率,而负Δ-HDL 和Δ中性粒细胞与淋巴细胞比值则增加了进展的几率。另一方面,负Δ-TG 和正Δ-HDL 显著增加了 IDF 和 ATP III 两种情况下 MetS 消退的几率。管理高甘油三酯血症、高血糖和高密度脂蛋白(HDL)是改变 MetS 趋势的关键、非侵入性和可及的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/120d/7659336/0df5a74ead22/41598_2020_76531_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验